Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer.
Hayward S, Gachehiladze M, Badr N, Andrijes R, Molostvov G, Paniushkina L, Sopikova B, Slobodová Z, Mgebrishvili G, Sharma N, Horimoto Y, Burg D, Robertson G, Hanby A, Hoar F, Rea D, Eckhardt BL, Ueno NT, Nazarenko I, Long HM, van Laere S, Shaaban AM, Berditchevski F. Hayward S, et al. Among authors: hanby a. J Pathol. 2020 May;251(1):63-73. doi: 10.1002/path.5415. Epub 2020 Mar 24. J Pathol. 2020. PMID: 32129471
Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study.
Shaw EC, Hanby AM, Wheeler K, Shaaban AM, Poller D, Barton S, Treanor D, Fulford L, Walker RA, Ryan D, Lakhani SR, Wells CA, Roche H, Theaker JM, Ellis IO, Jones JL, Eccles DM. Shaw EC, et al. Among authors: hanby am. J Clin Pathol. 2012 May;65(5):403-8. doi: 10.1136/jclinpath-2011-200369. Epub 2012 Mar 23. J Clin Pathol. 2012. PMID: 22447915
Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
Romanska HM, Potemski P, Krakowska M, Mieszkowska M, Chaudhri S, Kordek R, Kubiak R, Speirs V, Hanby AM, Sadej R, Berditchevski F. Romanska HM, et al. Br J Cancer. 2015 Nov 3;113(9):1350-7. doi: 10.1038/bjc.2015.344. Epub 2015 Sep 29. Br J Cancer. 2015. PMID: 26418423 Free PMC article.
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.
Westbrook JA, Wood SL, Cairns DA, McMahon K, Gahlaut R, Thygesen H, Shires M, Roberts S, Marshall H, Oliva MR, Dunning MJ, Hanby AM, Selby PJ, Speirs V, Mavria G, Coleman RE, Brown JE. Westbrook JA, et al. Among authors: hanby am. J Pathol. 2019 Mar;247(3):381-391. doi: 10.1002/path.5197. Epub 2019 Jan 25. J Pathol. 2019. PMID: 30426503 Free PMC article.
Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.
Al-Nakhle H, Burns PA, Cummings M, Hanby AM, Hughes TA, Satheesha S, Shaaban AM, Smith L, Speirs V. Al-Nakhle H, et al. Among authors: hanby am. Cancer Res. 2010 Jun 1;70(11):4778-84. doi: 10.1158/0008-5472.CAN-09-4104. Epub 2010 May 18. Cancer Res. 2010. PMID: 20484043 Free PMC article.
250 results